248 results on '"Kenzey, Chantal"'
Search Results
2. Impact of allele-level HLA matching on outcomes after double cord blood transplantation in adults with malignancies
3. Outcomes of subsequent neoplasms after umbilical cord blood transplantation in Europe
4. Unsupervised Clustering Analysis of Regimen and HLA Characteristics in Pediatric Umbilical Cord Blood Transplantation
5. Umbilical Cord Blood Transplantation for Fanconi Anemia With a Special Focus on Late Complications: a Study on Behalf of Eurocord and SAAWP-EBMT
6. Umbilical cord blood transplants facilitated by the French cord blood banks network. On behalf of the Agency of Biomedicine, Eurocord and the French society of bone marrow transplant and cell therapy (SFGM-TC)
7. Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation.
8. Impact of COVID-19 pandemic on the use and release of cord blood units facilitated by the French Cord Blood Banks Network: on behalf of the Agency of Biomedicine, Eurocord and the French Society of Bone Marrow Transplant and Cell Therapy (SFGM-TC)
9. Cord blood transplantation for adult lymphoid neoplasms in Europe and Japan
10. HLA-Matched Unrelated Donors for Patients with Sickle Cell Disease: Results of International Donor Searches
11. Myeloablative Unrelated Cord Blood Transplantation in Adolescents and Young Adults with Acute Leukemia
12. HLA peptide‐binding pocket diversity modulates immunological complications after cord blood transplant in acute leukaemia.
13. Cord Blood Unit Dominance Analysis and Effect of the Winning Unit on Outcomes after Double-Unit Umbilical Cord Blood Transplantation in Adults with Acute Leukemia: A Retrospective Study on Behalf of Eurocord, the Cord Blood Committee of Cellular Therapy, Immunobiology Working Party, and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
14. Low Body Mass Index Is Associated with Increased Risk of Acute GVHD after Umbilical Cord Blood Transplantation in Children and Young Adults with Acute Leukemia: A Study on Behalf of Eurocord and the EBMT Pediatric Disease Working Party
15. Umbilical Cord Blood Transplantation after Graft Failure from a Previous Hematopoietic Stem Cell Transplantation
16. Use of letermovir in umbilical cord blood transplantation based on risk scores
17. Long-Term Outcomes of Cord Blood Transplantation from an HLA-Identical Sibling for Patients with Bone Marrow Failure Syndromes: A Report From Eurocord, Cord Blood Committee and Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation
18. Umbilical Cord Blood Cytomegalovirus Serostatus Does Not Have an Impact on Outcomes of Umbilical Cord Blood Transplantation for Acute Leukemia
19. Allele-level HLA matching for umbilical cord blood transplantation for non-malignant diseases in children: a retrospective analysis
20. Chronic graft-versus-host disease features in double unit cord blood transplantation according to National Institutes of Health 2005 cGVHD Consensus criteria
21. Outcomes after Unrelated Umbilical Cord Blood Transplantation for Children with Osteopetrosis
22. HLA haplotype frequencies and diversity in patients with hemoglobinopathies.
23. Impact of ATG-containing reduced-intensity conditioning after single- or double-unit allogeneic cord blood transplantation
24. Impact of Allele-Level HLA-Matching on Outcomes after Double Unrelated Cord Blood Transplantation in Adults with Malignant Diseases
25. Comparative analysis of the variability of the human leukocyte antigen peptide‐binding pockets in patients with acute leukaemia
26. Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies
27. Possible Effect of the use of Mesenchymal Stromal Cells in the Treatment of Autism Spectrum Disorders: A Review
28. Umbilical Cord Blood Transplantation after Graft Failure from a Previous Hematopoietic Stem Cell Transplantation
29. Comparative analysis of the variability of the human leukocyte antigen peptide‐binding pockets in patients with acute leukaemia.
30. Umbilical Cord Blood Transplantation after Graft Failure from a Previous Hematopoietic Stem Cell Transplantation
31. Impact of COVID-19 pandemic on the use and release of cord blood units facilitated by the French Cord Blood Banks Network: on behalf of the Agency of Biomedicine, Eurocord and the French Society of Bone Marrow Transplant and Cell Therapy (SFGM-TC)
32. Impact of the human leucocyte antigen (HLA)‐B leader peptide dimorphism and HLA‐A expression on outcomes of stem cell transplantation for sickle cell disease
33. Unsupervised Clustering Analysis of Regimen and HLA Characteristics Identifies Subgroups with Improved Relapse-Free Survival in Children with ALL and AML Undergoing Umbilical Cord Blood Transplantation
34. Outcomes and Late Complications after Umbilical Cord Blood Transplantation for Fanconi Anemia: A Study on Behalf of Eurocord and Severe Aplastic Anemia Working Party - EBMT
35. Use of the HLA-B leader to optimize cord blood transplantation
36. Polymorphisms in Inflammatory Genes Modulate Clinical Complications in Patients With Sickle Cell Disease
37. Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR
38. Polymorphisms in Inflammatory Genes Modulate the Occurrence of Clinical Complications in Patients with Sickle Cell Disease
39. Human Leukocyte Antigen Matched Unrelated Donors for Patients with Sickle Cell Disease According to Geographic Origin: Results of International Donor Searches
40. A Toll‐like receptor 2 genetic variant modulates occurrence of bacterial infections in patients with sickle cell disease
41. Endothelial and Circulating Progenitor Cells in Hematological Diseases and Allogeneic Hematopoietic Stem Cell Transplantation
42. Outcomes of Advanced Hodgkin Lymphoma after Umbilical Cord Blood Transplantation: A Eurocord and EBMT Lymphoma and Cellular Therapy & Immunobiology Working Party Study
43. Early and late outcomes after cord blood transplantation for pediatric patients with inherited leukodystrophies
44. Low Body Mass Index Is Associated with Increased Risk of Acute GVHD after Umbilical Cord Blood Transplantation in Children and Young Adults with Acute Leukemia: A Study on Behalf of Eurocord and the EBMT Pediatric Disease Working Party
45. Early and late outcomes after cord blood transplantation for pediatric patients with inherited leukodystrophies
46. Cord Blood Unit Dominance Analysis and Effect of the Winning Unit on Outcomes after Double-Unit Umbilical Cord Blood Transplantation in Adults with Acute Leukemia:A Retrospective Study on Behalf of Eurocord, the Cord Blood Committee of Cellular Therapy, Immunobiology Working Party, and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
47. Cord Blood Transplantation in Adolescents and Young Adults with Acute Leukemia: On Behalf of Eurocord, Ctiwp and PDWP of EBMT
48. A Polymorphism in Toll-like Receptor 2 Gene Is Associated with Occurrence of Bacterial Infections in Sickle Cell Disease Patients
49. The Optimal Alternative Donor Transplant for Pediatric Patients with Acute Leukemia: A Comparison between Alfa-Beta T-Cell and B-Cell Depleted Haplo-SCT and UCBT
50. Outcomes of Advanced Hodgkin Lymphoma after Umbilical Cord Blood Transplantation: A Eurocord and EBMT Lymphoma and Cellular Therapy & Immunobiology Working Party Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.